Burillo-Sanz, S <br/><br/>
NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.  [electronic resource] 

 -  International journal of laboratory hematology  Feb 2016 
 - 64-71 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1751-553X 
<br/><br/><label>Standard No.: </label>10.1111/ijlh.12435  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>DNA-Binding Proteins--genetics<br/>Disease Management<br/>Female<br/>Gene Expression<br/>Gene Expression Profiling<br/>Homeodomain Proteins--genetics<br/>Humans<br/>Immunophenotyping<br/>In Situ Hybridization, Fluorescence<br/>Leukemia, Myeloid, Acute--diagnosis<br/>MDS1 and EVI1 Complex Locus Protein<br/>Myeloid Cells--metabolism<br/>Myeloid Ecotropic Viral Integration Site 1 Protein<br/>Neoplasm Proteins--genetics<br/>Neoplasms, Second Primary<br/>Nuclear Pore Complex Proteins--genetics<br/>Oncogene Proteins, Fusion--genetics<br/>Proto-Oncogenes--genetics<br/>Transcription Factors--genetics<br/>Translocation, Genetic<br/>fms-Like Tyrosine Kinase 3--genetics